Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hAESCs in Refractory Severe Intrauterine Adhesion
NCT03381807Phase 1Unknown
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Sep 2020
- Primary completion
- Sep 2022
- Modality
- Mesenchymal Stem Cells
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of human amniotic epithelial stem cells in Intrauterine Adhesions (IUA), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoints: Endometrial thickness at 9 months and Menstrual blood volume at 9 months. Status: unknown.
02
Drugs
human amniotic epithelial stem cells
03
Conditions
Intrauterine Adhesions (IUA)
Beyond the preview
Go deeper on NCT03381807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03381807.